In the ongoing trade war, China has significantly increased tariffs on U.S. goods from 84% to an unprecedented 125%. This move comes as a countermeasure to the Trump administration's similar actions.

RBC Capital analyst Gerard Cassidy reiterated a Sector Perform rating with a price target of $90 on March 17, 2025. This ...

Tesla unveils a new RWD Cybertruck trim with a 350 mile range, reduced towing capacity, no air suspension and a reduced price ...

Larry Summers countered claims of China cheating on trade, comparing it to institutions offering free tuition. Entrepreneur ...

Peter Schiff, a well-known economist, took to social media on Thursday to express his views on Bitcoin (CRYPTO: BTC) in the ...

Alibaba’s stock dipped 0.57% to close at $104.18, with an intraday high of $108.45 and a low of $101.37. The stock’s 52-week ...

Analysts have recently evaluated Dana and provided 12-month price targets. The average target is $18.71, accompanied by a ...

Levi Strauss & Co. (NYSE:LEVI) gets a bullish nod from BofA, highlighting its global brand strength, solid first-quarter ...

Goldman Sachs maintains Buy rating on ServiceNow, lowers price target to $1,050. ServiceNow has underperformed due to sub-20% fiscal 2025 guidance and tariff volatility.

IMAX Corporation (NYSE:IMAX) received a reiterated Buy rating and $35 price target from Rosenblatt, citing a blowout Q1 box ...

Bayer's Vitrakvi receives full FDA approval based on solid tumor data showing sustained efficacy in NTRK fusion-positive patients.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $21.0, along ...